Measurement of Cerebral Perfusion Indices from the Early Phase of [<sup>18</sup>F]MK6240 Dynamic Tau PET Imaging.
Where this comes from
- Record sourced from PubMed, PMID 36997330.
- Also identified by DOI 10.2967/jnumed.122.265072 and PMC identifier 10241011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
6-(fluoro-<sup>18</sup>F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([<sup>18</sup>F]MK6240) has high affinity and selectivity for hyperphosphorylated tau and readily crosses the blood-brain barrier. This study investigated whether the early phase of [<sup>18</sup>F]MK6240 can be used to provide a surrogate index of cerebral perfusion. <b>Methods:</b> Forty-nine subjects who were cognitively normal (CN), had mild cognitive impairment (MCI), or had Alzheimer's disease (AD) underwent paired dynamic [<sup>18</sup>F]MK6240 and [<sup>11</sup>C]Pittsburgh compound B (PiB) PET, as well as structural MRI to obtain anatomic information. Arterial blood samples were collected in a subset of 24 subjects for [<sup>18</sup>F]MK6240 scans to derive metabolite-corrected arterial input functions. Regional time-activity curves were extracted using atlases available in the Montreal Neurologic Institute template space and using FreeSurfer. The early phase of brain time-activity curves was analyzed using a 1-tissue-compartment model to obtain a robust estimate of the rate of transfer from plasma to brain tissue, <i>K</i> <sub>1</sub> (mL⋅cm<sup>-3</sup>⋅min<sup>-1</sup>), and the simplified reference tissue model 2 was investigated for noninvasive estimation of the relative delivery rate, <i>R</i> <sub>1</sub> (unitless). A head-to-head comparison with <i>R</i> <sub>1</sub> derived from [<sup>11</sup>C]PiB scans was performed. Grouped differences in <i>R</i> <sub>1</sub> were evaluated among CN, MCI, and AD subjects. <b>Results:</b> Regional <i>K</i> <sub>1</sub> values suggested a relatively high extraction fraction. <i>R</i> <sub>1</sub> estimated noninvasively from simplified reference tissue model 2 agreed well with <i>R</i> <sub>1</sub> calculated indirectly from the blood-based compartment modeling (<i>r</i> = 0.99; mean difference, 0.024 ± 0.027), suggesting that robust estimates were obtained. <i>R</i> <sub>1</sub> measurements obtained with [<sup>18</sup>F]MK6240 correlated strongly and overall agreed well with those obtained from [<sup>11</sup>C]PiB (<i>r</i> = 0.93; mean difference, -0.001 ± 0.068). Statistically significant differences were observed in regional <i>R</i> <sub>1</sub> measurements among CN, MCI, and AD subjects, notably in the temporal and parietal cortices. <b>Conclusion:</b> Our results provide evidence that the early phase of [<sup>18</sup>F]MK6240 images may be used to derive a useful index of cerebral perfusion. The early and late phases of a [<sup>18</sup>F]MK6240 dynamic acquisition may thus offer complementary information about the pathophysiologic mechanisms of the disease.
Medical subject headings
- Alzheimer Disease
- Cognitive Dysfunction